Advertisement

COVID-19 Federal Responses: Thursday, July 7, 2022

COVID-19 Federal Responses: Thursday, July 7, 2022
  • A review of 18 studies found that long-distance airborne transmission (qualified as transmission from two or more meters away) of COVID-19 is possible in indoor settings. The studies identify a lack of airflow and ventilation as a leading cause in environments such as the workplace or restaurants.
  • Researchers from UT Southwestern developed a new COVID-19 test that can identify what variant a COVID-positive patient has been infected with, which would potentially influence individual treatment decisions.
  • Preliminary data from a Veterans Affairs health system study shows that immune protection from both COVID-19 vaccines and COVID-19 past infections are strong, however, reinfection can still increase the likelihood of new health issues.
  • Sabizabulin, a drug created by Veru Inc. initially with the hopes of treating cancer patients, has been found to potentially cut the risk of death among high risk COVID-19 positive patients by significant margins.
  • The FDA instructed pharmaceutical companies that any new COVID-19 booster shot in development must include added protection against the Omicron variant and its subvariants.
  • The FDA announced that it will allow state-licensed pharmacists to directly prescribe Paxlovid to COVID-19 patients.

White House and Federal Agencies

  • The FDA instructed pharmaceutical companies that any new COVID-19 booster shot in development must include added protection against the Omicron variant and its subvariants.
  • The FDA announced that it will allow state-licensed pharmacists to directly prescribe Paxlovid to COVID-19 patients.

Economy, Vaccines, Testing and Treatment

  • According to research conducted in March by the CDC, 40% of rural area parents said that their pediatricians did not recommend the COVID-19 vaccines. By comparison, only 10% of parents in urban communities said the same.
  • A review of 18 studies has found that long-distance airborne transmission (qualified as transmission from 2 or more meters away) of COVID-19 is possible in indoor settings. The studies identify a lack of airflow and ventilation as a leading cause in environments such as the workplace or restaurants.
  • Researchers at the National Institute of Health released data indicating that between March 2020 and October 2021, COVID-19 was the third leading cause of death in the U.S.
  • The Omicron subvariant BA.5 now accounts for the majority of U.S. COVID-19 cases.
  • Researchers from UT Southwestern developed a new COVID-19 test that can identify which variant a COVID-positive patient has been infected with, which would potentially influence individual treatment decisions.
  • Preliminary data from a Veterans Affairs health system study shows that immune protection from both COVID-19 vaccines and COVID-19 past infections are strong; however, reinfection can still increase the likelihood of new health issues.
  • Sabizabulin, a drug created by Veru Inc. initially with the hopes of treating cancer patients, has been found to potentially cut the risk of death among high-risk COVID-19 positive patients by significant margins.
  • The COVID-19 pandemic has been implicated as a cause for the biggest decrease in US life expectancy since World War II.

 

Advertisement